Romidepsin Used as Monotherapy in Sequence with Allogeneic Stem Cell Transplant in a Patient with Peripheral T-Cell Lymphoma
Despite advances in the field, a clear treatment algorithm for most peripheral T-cell lymphoma (PTCL) subtypes remains to be defined. Generating reliable randomized data for this type of pathology remains a challenge because of the relative rarity of the disease and the heterogeneity of subtypes. Ne...
Saved in:
| Main Authors: | Nicholas Finn, Jean-Francois Larouche |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2014/404078 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma with Hemophagocytic Syndrome Treated with Romidepsin and Allogeneic Hematopoietic Cell Transplantation
by: Yuki Ishizawa, et al.
Published: (2025-02-01) -
Impact of Autologous and Allogeneic Stem Cell Transplantation in Peripheral T-Cell Lymphomas
by: Peter Reimer
Published: (2010-01-01) -
MYCOSIS FUNGOIDES PROGRESSING TO PERIPHERAL T-CELL LYMPHOMA AND THE POTENTIAL ROLE OF ROMIDEPSIN THERAPY
by: Bengisu Ece Duman, et al.
Published: (2024-12-01) -
Real-world evidence of duvelisib and romidepsin in relapsed/refractory peripheral and cutaneous T-cell lymphomas
by: Josie G. Ford, et al.
Published: (2025-08-01) -
The Role of Allogeneic Stem Cell Transplantation in Adult Patients With Peripheral T-Cell Lymphoma: A Systematic Review and Meta-Analysis
by: Ahmad Alazzam, et al.
Published: (2025-06-01)